Press Release

Egypt Pharmaceutical Market to be Dominated by Target Therapy Through 2028

The increasing demand for colored pharmaceuticals as a fashion accessory is expected to drive the growth of the Egypt Pharmaceutical market during the forecast period, 2024-2028.

According to the TechSci Research report, “Egypt Pharmaceutical Market - By Region, Competition, Forecast and Opportunities, 2028” Egypt Pharmaceutical Market is projected to increase at an impressive rate during the forecast period, 2024-2028. The factors responsible for the growth of the market are the increasing prevalence of chronic diseases in Egypt, along with rising research and development in pharmaceuticals. Furthermore, the development of personalized medicines in the market is anticipated to fuel the pharmaceutical market expansion throughout the forecast period. Moreover, the rising elderly population with various communicable diseases such as tropical and vector borne diseases, tuberculosis, coronavirus infections, dengue, hepatitis along with non-communicable diseases such as cardiovascular diseases., cancers, diabetes, chronic respiratory diseases. is anticipated to support the growth of the market during the forecast period. 

However, factors hampering the overall growth of the Egypt pharmaceutical market are stringent regulation along with delayers regulatory approvals. Moreover, absence of technical support miscommunication between governmental and pharmaceutical regulatory affairs, the gap between academia and industry, and regulatory, developmental, and manufacturing challenges beginning with product registration are limiting the growth of the market.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on the "Egypt Pharmaceutical Market

Egypt pharmaceutical market is segmented on the basis of type, drug classification, mode of purchase, and distribution channels.

Based on type, the market is further divided into pharmaceutical drugs and biologics. Pharmaceutical drugs is expected to increase at a high CAGR in the Egypt Pharmaceutical market. The demand for medicines due to increasing chronic diseases is expected to fuel market expansion. Moreover, Monoclonal Antibodies (MAbS) and Therapeutic Proteins, Vaccines are anticipated to support the growth of the market throughout the forecast period, 2024-2028.

Based on drug classification the market is segmented into branded drugs and generic drugs. The generic drugs segment is expected to drive the growth of the market throughout the forecast period, 2024-2028. The primary reason fueling this market's growth is the rapid patent expiration of branded medications. Diabetes and cardiovascular disorders, which are becoming more common, are also anticipated to hasten the market's total expansion. Further, increased spending on intensive research and development projects as well as formulation innovations such fixed dose combinations and cost-effective treatments are also anticipated to temper market expansion. Additionally, it is predicted that the numerous licensing and partnering techniques used by major vendors to introduce new products, which will create lucrative prospects for the market. The preference for less expensive solutions in recent government reimbursement systems will increase the growth pace of the generic medication market in the future.

Based on the mode of purchase, the market is further divided into prescription-based drugs, and over-the-counter drugs. The prescription-based drugs segment is expected to hold the largest market share during the forecast period, 2024-2028. Numerous vaccines and treatments for acute and chronic illnesses are included in prescription drugs. These conditions include diabetes, cancer, cardiovascular disease, and orphan diseases. Effective prescription drug administration is essential in today's therapeutic environment for enhancing clinical outcomes for virtually every patient suffering from serious disorders.

Major companies operating in the Egypt Pharmaceutical Market are:

  • MDI Pharma
  • Merck & Co.
  • Novartis AG
  • Pharco Pharmaceuticals
  • Roche Holding AG
  • Sanofi S.A
  • EVA Pharma
  • Orchidia Pharmaceutical Industries
  • GlaxoSmithKline
  • Tabuk Pharmaceuticals

Download Free Sample Report

Customers can also request for 10% free customization on this report.

Based on distribution channels, the market is further divided into hospital pharmacies, retail pharmacies, and online pharmacies. One of the main factors contributing to hospital pharmacies' domination in the market is the fact that the therapies listed under prescription pharmaceuticals are frequently only able to be prescribed in hospital settings under the supervision of qualified medical personnel. Additionally, a variety of medications used to treat serious illnesses including cancer and orphan diseases can only be given intravenously by qualified medical personnel. Clinical outcomes are frequently improved as a result of the right treatment and management of important diseases made possible by such excellent therapeutic administration.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Egypt management consulting firm.

Egypt Pharmaceutical Market- Type{Pharmaceutical Drugs (Gynecology Drugs, Respiratory Drugs, Dermatology Drugs, Analgesic Drugs, Oncology Drugs, Others) and Biologics (Monoclonal Antibodies (MAbS, Therapeutic Proteins, Vaccines)}, By Drug Classification (Branded Drugs v/s Generic Drugs), By Mode of Purchase (Prescription-Based Drugs v/s Over-the-counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company and By Region, has evaluated the future growth potential of Egypt Pharmaceutical Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Egypt Pharmaceutical Market.”

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web:  https://www.techsciresearch.com

Relevant News